BBTV

About Us

Wall Street on BBTV

all episodes

VICL – Vical CEO Vijay Samant interviewed by Stephen Willey

  1. DNA Vaccines, a Fast and Efficient ‘Plug-N-Play’ Technology
  2. Allovectin-7, a Phase 3 Cancer Immunotherapy for Head & Neck Tumors
  3. TransVax, a Phase 2 DNA Vaccine to Prevent Cytomegalovirus (CMV) Reactivation
  4. Vical’s Speed and Adaptability Play on Pandemic Influenza Appeals to Department of Defense for Military Vaccines
  5. Vical Licensors, Sanofi and Angios, in Phase 3 Trials on Multi-Billion Dollar PAD Market

  • Categories

    • Shows
      • Biotech in the Money
      • Wall Street on BBTV
      • Science Breakthrough
      • The Jan Buck Show
      • 60sec Pitches
      • Special Interview
      • Report on Location
      • Wall Street
    • Series
      • The Stem Cell Review
      • Alzheimer's Today
      • The MedTech Report
      • Stem Cell Review
    • Channels
      • Science
      • Finance
      • Business
    • About
      • about sub
      • about sub 2

  • Acknowlegments

    nasdaq nasdaq

  • About the Series

    The Stem Cell Review is a 10-part original series on the science, medical applications, and business of stem cells.

    This program will give you a clear and concise understanding of the state of stem cells today, with the additional depth and expertise you would come to expect from the most renown authorities in the field.

    The Stem Cell Review is a BioBusiness.TV Original Program, presented by Bill Kridel, produced by Jean-Loup Romet-Lemonne and Jonathan Teper.

  • Channels
    • Science
  • Series
    • The Stem Cell Review
  • Shows
    • Biotech in the Money
    • Report on Location
    • Science Breakthrough
    • Special Interview
    • The Jan Buck Show
    • Wall Street
    • Wall Street 2
    • Wall Street on BBTV
  • About
    • about sub
    • about sub 2